Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With <i>S. Aureus</i> Osteomyelitis and Their Association With Clinical Outcome Following Surgery in a Clinical Pilot.

Front Cell Infect Microbiol · 2022 · PMC9339635 · PMID 35923804

Europe PMC DOI

hedged sentence

0.0080

closest p · 0.2× alpha

0.0080

boldest claim

The sentences

highly significantp=0.008actually significant

Furthermore, patients with low anti-Gmd titer demonstrated a highly significant 2.7-fold increased risk in adverse outcomes (p=0.008).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With &lt;i&gt;S. Aureus&lt;/i&gt; Osteomyelitis and Their Association With Clinical Outcome Following Surgery in a Clinical Pilot.

The sentences

Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With <i>S. Aureus</i> Osteomyelitis and Their Association With Clinical Outcome Following Surgery in a Clinical Pilot.